Category :

Pharmaceuticals and Biotech Press Releases

Sponsor-Facilitated Relationships Between Late Stage Researchers and Phase 1 Sites: A Novel Model for Early Phase Studies, New Webinar Hosted by Xtalks

Join Maria Apkarian, Vice President of Early Clinical Development at WCCT Global, for a live webinar upcoming on Wednesday, Oct. 31, 2018, at 1 p.m. EDT (10 a.m. PDT). Typically, early phase studies are conducted in somewhat of an isolated…

Solving Medical Technology Product Development Issues, New Webinar Hosted by Xtalks

There is an increasing number of emerging medical technologies (MedTech) which are having a significant effect on the medical equipment and medical device industries. The main principles that come into play when applying these new medical technologies are design for…

Pfizer and Bracket – How to Apply Patient-Centric Concepts to All Stages of Clinical Trials, New Webinar Hosted by Xtalks

Let’s move beyond the protocol and unlock the power of your study conduct before, during, and after your trial: Before: Additional advantages of pre-trial planning During: Cutting-edge tools and tactics to optimize the patient experience After: Post-trial gratitude and community…

Fit-for-Future Pharmacovigilance Sourcing Strategies, New Webinar Hosted by Xtalks

The challenges and demands of pharmacovigilance in today’s climate has shifted significantly. How do we determine what should and can be sourced differently compared to our traditional models? Offshore-outsourced blended models are becoming increasingly popular. Join Humaira Qureshi, SVP of…

NeuroDiagnostics, LLC New Alzheimer's Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration

NeuroDiagnostics, LLC, a privately held neurological diagnostics company, announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to NeuroDiagnostics’ DISCERNTM multiple biomarker test for Alzheimer’s Disease. If approved, this test could be the first…

Alpha Genesis Indonesian Macaques Show Unique Research Potential

Alpha Genesis Indonesian Macaques Show Unique Research Potential

​​​Alpha Genesis has announced that it now provides purpose-bred Indonesian-origin cynomolgus macaques for use in vaccine development and other select study applications. The primate science corporation serves medical research organizations throughout the world, including several European and Asian drug-development companies. The…

How Animal Behavioral Management and Environmental Enrichment Enhances Preclinical Research Performance, New Webinar Hosted by Xtalks

In a live webinar taking place on Tuesday, October 30, 2018 at 11 a.m. EDT (3 p.m. GMT), featured speakers will explore how each intervention throughout the research cycle results in time efficiency, cost savings, improved safety and ultimately enhanced research…

How to Destroy Clinical Data Silos, New Webinar Hosted by Xtalks

Speed to insight is the key to the operational success of running a study, a country, a region, or a large portfolio of studies. However, this can be complicated by multiple people working on a study or portfolio with divergent…

Diagnomics Partners With Translational Software to Launch Pharmacogenetic Testing Services in the United States

Diagnomics Inc., a San Diego-based genomics solution provider, has extended its product portfolio to include pharmacogenetic (PGx) reporting through a strategic partnership with Translational Software Inc. (TSI). Diagnomics is one of the first companies to offer clinically validated PGx solutions on Illumina’s Global…

Applying the Latest Digital Technology Trends to Patient, Provider and Payer Communications, New Webinar Hosted by Xtalks

Have you wondered how the Internet of Things (IoT) will impact healthcare and pharmaceutical communications? If you are curious about the latest digital trends and how that innovation is being implemented into real-world communication needs, don’t miss this live webinar…

Trends in Site Payments: Insight Into How CROs Can Gain a Competitive Edge, New Webinar Hosted by Xtalks

This live webinar upcoming on Thursday, October 25, 2018, at 1 p.m. EDT (10 a.m. PDT) will focus on the latest market research exploring trends in sponsor site payment strategies and criteria used to measure success. CROs will gain insight…

Vascular Stress Contributes to Age-Associated Vision Loss

An article published in Experimental Biology and Medicine (Volume 243, Issue 12, August, 2018 (http://journals.sagepub.com/doi/full/10.1177/1535370218794915) reports that vascular stress exacerbates age-associated vision loss. The study, led by Dr. Rajashekhar Gangaraju, in the Department of Ophthalmology and the Department of Anatomy…

TherigySTM™ Surpasses 100 Million Specialty Patient Responses

Therigy LLC, the trusted specialty pharmacy software and consulting company, has reached a noteworthy milestone for its TherigySTM™ software – 100,000,000 patient engagement activity and assessment responses. Ten years ago, TherigySTM™ became the industry’s first software-as-a-service (SaaS) therapy management technology platform. The…

Inhalation Drug Delivery: Considerations for Toxicology and Pharmacology Research, New Webinar Hosted by Xtalks

Drug delivery to the lungs in both the clinical and non-clinical setting is a unique combination of formulation, delivery device and the system/model that the drug is being delivered to. Throughout different stages of drug development, the requirements for inhalation…

FDA Grants Coordination Pharmaceuticals IND Approval for CPI-100, a Novel Antitumor Nanomedicine

Coordination Pharmaceuticals, Inc. (CPI), a privately held and clinical-stage biopharmaceutical company focused on nanotechnology-based cancer immunotherapy, announced today that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application to initiate a first-in-human Phase…

Therigy Outcomes Contributions Recognized by National Association of Specialty Pharmacy

On September 26, 2018, Therigy’s Chief Clinical Officer (CCO), Lily Duong, PharmD, RPh, and Khang Tran, PharmD, were awarded first place in the “Delivery of Specialty Pharmacy Products or Services” category for their scientific poster presentation at NASP’s 2018 Annual…

Better Target Validation for Drug Discovery With CRISPR/Cas9, New Webinar Hosted by Xtalks

Join our keynote speaker, Jon Moore, CSO at Horizon Discovery, for a live session on Tuesday, Oct. 23, 2018. Horizon Discovery has used CRISPR/Cas9 to perform pooled screens of a 3,000-gene library, that includes protein and lipid kinases against a panel…

Fluorescently-Labeled Peptides – Choosing the Best Dye and Designing the Best Peptide, New Webinar Hosted by Xtalks

Peptides fulfil numerous important tasks in nature. The investigation of such peptides in their natural environment is complex and requires specific techniques such as confocal microscopy. In order to study peptides with a confocal microscope, the peptide needs to be…

Venerated and Vital: Using Lipid Based Delivery for Fast and Efficient Early Phase Development, Upcoming Webinar Hosted by Xtalks

In a live session on Tuesday, October 16, 2018 at 11 a.m. EDT (4 p.m. BST/UK), viewers can learn how to apply lipid-based drug delivery systems to early phase molecules by joining academic and industry experts to develop a better understanding of…

Captek | Pharma Exhibiting at Contract Pharma Conference in 2018, Booth 151

Captek Pharma announces its participation as an exhibitor at the 17th Annual Contract Pharma trade show Sept. 27–28, 2018, in New Brunswick, New Jersey. Representatives will be at Booth 151 to discuss their brand-new facility and answer questions about their product and…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login